Investing
Insider Buying Volume Big as Trump Rally Rolls On: Transdigm, Medicines Company, Medley Capital, W&T Offshore and More
Published:
Last Updated:
Another week, another solid performance for stocks, as the rally that started after the presidential election continues. We believe that it is very possible the Trump rally could have legs into January, as investors may want to put off taking capital gains this year with the potential for tax cuts on the table for 2017. With insiders still buying, the scenario for stocks looks solid.
We cover insider buying each week at 24/7 Wall St., and we like to remind readers that while insider buying is usually a very positive sign, it is not in of itself a reason to run out and buy a stock. Sometimes insiders and 10% owners have stock purchase plans set up at intervals to add to their holdings. That aside, it still remains an overall positive indicator.
Also check out our look at recent insider selling at Valeant Pharmaceuticals, Starbucks, Schlumberger and more.
Here are some of the companies that reported notable insider buying last week:
Transdigm Group Inc. (NYSE: TDG) had a director at the company step in and buy stock in a big way last week. That director purchased a total of 91,000 shares of the stock at prices ranging from $247.16 to $247.89. The total for the trade came in near $22.7 million. The company designs, produces and supplies aircraft components in the United States. Its stock closed trading last Friday at $251.488.
Transcontinental Realty Investors Inc. (NYSE: TCI) saw its chief executive officer purchasing stock last week. Daniel Moos bought a block of 285,000 shares at $10.60 apiece. The trade cost him right at $3 million. The company acquires, develops and owns residential and commercial real estate properties through acquisitions, leases and partnerships in the United States. Its shares closed Friday at $11.48.
Medicines Co. (NASDAQ: MDCO) hits our screens again, and this time an executive vice president is acquiring shares. That executive bought a total of 105,500 shares at prices that ranged from $32.52 to $33.33. The total for the purchase was a strong $3.5 million. The company provides medicines for patients in acute and intensive care hospitals worldwide. The stock closed Friday at $36.77, so the timing looks outstanding.
Medley Capital Corp. (NYSE: MCC) is another company that had the man at the top buying shares. CEO Brook Taube added 188,336 shares of the business development company at prices that ranged from $7.13 to $7.48 per share. The total for the trade was posted at $1 million. The stock closed Friday at $7.26.
W&T Offshore Inc. (NYSE: WTI) had a big buy hit the tape last week. CEO Tracy Krohn picked up a massive 1,180,888 shares of the independent oil and natural gas producer at $1.94 per share. The total for the trade came in right at the $2 million level. The company engages in the acquisition, exploration and development of oil and natural gas properties in the Gulf of Mexico. The stock closed Friday at $2.67, so outstanding timing, indeed.
These companies also reported insider buying last week: Medtronic PLC (NYSE: MDT), Sohu.com Inc. (NASDAQ: SOHU), Tandy Leather Factory Inc. (NASDAQ: TLF), United Technologies Corp. (NYSE: UTX) and Viacom Inc. (NASDAQ: VIAB).
With insiders buying shares at these lofty levels of the market, it’s a good bet they are very positive on their companies going forward. That’s a bullish sign for stock investors as we wrap up 2016.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on 247wallst.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.